Latest Articles

Publication Date
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nature.com

Published: April 23, 2024, 7 a.m.
Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study | Scientific Reports - Nature.com

Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study | Scientific Reports Nature.com

Published: April 10, 2024, 7 a.m.
The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers - Nature.com

The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers Nature.com

Published: April 6, 2024, 7 a.m.
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor

Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers Cancer Therapy Advisor

Published: March 17, 2024, 7 a.m.
A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis - Nature.com

A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis Nature.com

Published: Feb. 12, 2024, 8 a.m.
World Cancer Day 2024: 5 common cancers in women beyond cervical cancer - Hindustan Times

World Cancer Day 2024: 5 common cancers in women beyond cervical cancer Hindustan Times

Published: Feb. 4, 2024, 8 a.m.
Gynecologic cancers: Early detection and understanding symptoms can save lives - University of Alabama at Birmingham

Gynecologic cancers: Early detection and understanding symptoms can save lives University of Alabama at Birmingham

Published: Jan. 26, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!